Gastroenterology
Volume 124, Issue 4 , Pages 889-893, April 2003

Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis☆☆☆★

Presented in part at the 102nd Annual Meeting of the American Gastroenterological Association, May 20-23, 2001, Atlanta, Georgia (Gastroenterology 2001;120:A447).

Division of Gastroenterology and Hepatology and Division of Biostatistics, Mayo Clinic and Foundation, Rochester, Minnesota

Received 2 October 2002; accepted 20 December 2002.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Address requests for reprints to: Darrell S. Pardi, M.D., 200 First Street SW, Rochester, Minnesota 55905. e-mail: pardi.darrell@mayo.edu; fax: (507) 284-5486.

☆☆ Dr. Keith Lindor receives research funding from Axcan.

★ 0016-5085/03/$30.00

PII: S0016-5085(03)00070-2

Gastroenterology
Volume 124, Issue 4 , Pages 889-893, April 2003

Article Tools

* Image Usage & Resolution